Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New vitamin D analogues claimed

Aug. 19, 2011

Novel antitumor agents disclosed by Chinese and U.S. team

Aug. 19, 2011

New antitumor agents synthesized by Kyowa Hakko Kirin

Aug. 19, 2011

Dual FGF/VEGF pathway inhibitor shows promise in limiting tumor resistance to VEGF inhibition

Aug. 18, 2011

Roche obtains FDA approval for melanoma drug and companion diagnostic

Aug. 18, 2011

New prodrugs of proteasome inhibitors designed by Cephalon

Aug. 18, 2011

Allos Therapeutics begins phase III registration trial of Folotyn

Aug. 18, 2011

Emergent BioSolutions begins trial of TRU-016 in relapsed, indolent lymphoma

Aug. 18, 2011

Clavis reports interim results from phase II trial of elacytarabine/idarubicin combination

Aug. 17, 2011

Genetically altered T cells eradicate chronic lymphocytic leukemia cells in patients

Aug. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...